IGHE and allergic disease: To further determine whether maternal TMC3115 treatment could affect the susceptibility of offspring to IgE-mediated allergic diseases, and to investigate the underlying mechanisms, an OVA-stimulated model was used, involving offspring from PND 21–PND 49.